Effect of a Weight Loss Program on Body Composition and Metabolic Syndrome Markers in Obese Weight Cyclers by Oetoro, Samuel et al.
199
ORIGINAL ARTICLE
Acta Medica Indonesiana - The Indonesian Journal of Internal Medicine
Effect of a Weight Loss Program on Body Composition  
and Metabolic Syndrome Markers in Obese Weight Cyclers
Samuel Oetoro1, Lukman H. Makmun2, Widjaja Lukito1, Andi Wijaya3
1 Department of Nutrition, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
2 Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, 
Jakarta, Indonesia.
3 Post Graduate Program in Clinical Biochemistry, Universitas Hasanuddin, Makassar, Indonesia.
Correspondence mail:
Samuel Oetoro. Department of Nutrition, Faculty of Medicine, Universitas Indonesia. Jl. Mangga 15 blok U no. 1 
Kepa Duri Kebon Jeruk, Jakarta 11510, Indonesia. email: dr_samoetoro@yahoo.com.
ABSTRAK
Tujuan: untuk menilai pengaruh program penurunan berat badan (BB) terhadap massa lemak (ML), rating 
lemak viseral, dan parameter sindrom metabolik pada penyandang obesitas dengan weight cycling (WC). 
Metode: penelitian ini merupakan rancangan penelitian uji klinis terbuka selama 8 minggu yang dilakukan di 
Balai Kota DKI Jakarta. Subyek penelitian diambil secara konsekutif dan selanjutnya diklasifikasikan menjadi 
kelompok WC dan first encounter obesity (FEO). Kedua kelompok diberikan program penurunan BB yang 
terdiri dari pengurangan asupan energi sebesar 1000 kkal dan olahraga intensitas ringan - sedang tiga kali 
seminggu selama 45 menit. Pengukuran komposisi tubuh (ML, rating lemak viseral), dan petanda sindrom 
metabolik (lingkar pinggang/LP dan  kadar trigliserida.TG) dilakukan pada awal penelitian, minggu ke 4 dan 
pada akhir penelitian. Hasil: sebanyak 72 subyek berhasil menyelesaikan penelitian (34 orang pada kelompok 
WC dan 38 orang pada kelompok FEO). Pada akhir penelitian,  ML, rating lemak viseral, dan LP menurun pada 
kedua kelompok di mana penurunannya lebih kecil pada kelompok WC dibandingkan kelompok FEO; namun 
tidak berbeda bermakna (p >0,05). Kadar TG menurun pada kelompok FEO sedangkan pada kelompok WC 
didapatkan peningkatan kadar TG namun tidak berbeda bermakna (p=0,055). Kesimpulan: program penurunan 
BB dapat mempengaruhi komposisi tubuh dan petanda sindroma metabolik pada penyandang obesitas, namun 
responnya tampak lebih buruk pada penyandang obesitas dengan WC.
Kata kunci: progam penurunan berat badan, weight cycling, massa lemak, rating lemak viseral, sindrom 
metabolik.
ABSTRACT
Aim: to evaluate the effect of weight loss program on fat mass, visceral fat rating and metabolic syndrome 
markers in obese subjects with weight cycling. Methods: this was an 8-week open trial. The subjects were 
recruited consecutively from Balai Kota DKI Jaya. Subjects were classified into two groups according to the 
fluctuation of weight gain (weight cycling/WC and first encounter obesity/FEO group). Both groups were assigned 
to receive weight loss program consisted with following goals: a 1000 kcal energy intake reduction and 45 
minutes mild-to-moderate intensity physical activity three times a week. Body composition (fat mass, visceral 
fat rating), and metabolic syndrome markers (waist circumference and triglyceride levels) were measured at 
baseline, week 4 and at the end of study. Results: seventy two subjects completed the study (34 subjects in WC 
group and 38 subjects in FEO group). Following weight loss program, a decrease in fat mass, visceral fat 
rating, and waist circumference was lower in WC group compared with FEO group but it was not statistically 
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significant (p>0.05). Triglyceride levels were decreased in the FEO group while it was increased in WC group. 
However the difference was not significant (p=0.055). Conclusion: weight loss program may contribute to 
changes in body composition and metabolic syndrome markers in obese subjects, which the response appears 
to be worse in weight cyclers.
Key words: weight loss program, weight cycling, fat mass, visceral fat rating, metabolic syndrome.
INTRODUCTION
Obesity continuously becomes a public 
health problem with increasing prevalence every 
year. According to “Riset Kesehatan Dasar” 
(Riskerdas), prevalence of obesity in Indonesia 
increased significantly from 23.8% to 39.2% 
in women and 13.9% to 19.7% in men by year 
2013.1,2
Weight changes is strongly correlated with 
changes in body composition.3 Body composition 
changes in obesity is characterized by an increase 
in fat mass and decrease in fat-free mass. Review 
by Sun et al4 stated that adipocyte cell number 
is relatively constant by early adulthood so that 
any alterations of fat mass during adulthood are 
merely caused by adipocyte hypertrophy. The 
enlargement of adipocyte volume that is not 
accompanied by adequate angiogenesis can lead 
to cell hypoxia, adipocyte cell death, enhanced 
chemokine secretion, and dysregulation in 
fatty acid fluxes.5 These conditions will initiate 
inflammatory mediator secretion and moreover 
will induce systemic oxidative stress, which 
contributes to the development of the metabolic 
syndrome.6
Dietary program coupled with physical 
activity are considered the first-line strategy to 
manage obesity.7 The majority of individuals 
who lost weight could not maintain the reduced 
weight for a period of time. There are often 
repeated cycles of weight loss followed by weight 
regain, form a pattern known as weight cycling 
(WC) or “yo-yo”. Some experts have asserted 
that WC may increase the risk of developing 
metabolic syndrome and cardiovascular disease 
because of fat accumulation, central obesity, 
insulin resistance, and hypertension promoted by 
WC.8,9 Study by Zhang et al.10 reported a positive 
association between metabolic syndrome 
components and weight fluctuation that started 
from young adulthood. Until now, there is no 
conclusion whether weight cyclers will have 
more fat mass, visceral fat rating, and worse 
metabolic syndrome markers compared with 
obese individuals who never follow weight loss 
program (first encounter obesity/FEO).
We have not found published study has 
evaluated the effect of weight loss program 
in weight cycling population. Based on the 
background above, we conduct a pilot study to 
evaluate the effect of weight loss program (diet 
and exercise) on fat mass, visceral fat rating, and 
metabolic syndrome markers in obese subjects 
with weight cycling.
METHODS
Subjects 
Subjects were recruited from Balai Kota 
DKI Jaya (Jakarta City Hall). Potential subjects 
were initially screened by medical record review 
and those who appeared to be eligible were 
approached for consent. A written consent form 
was signed by all subjects prior to data collection.
Men and women aged 20-50 years old, had 
a body mass index (BMI) of between 30-35 kg/
m2, and with waist circumference >90 cm for 
man and >80 cm for woman, were included. 
The subjects were divided into two groups; WC 
and FEO group. Subjects who ever lost weight 
≥4.5 kg and regained weight at least three 
times in 4 years were included in former group; 
while those who never experienced weight 
loss were included in later group. Exclusion 
criteria were defined as fasting blood glucose 
≥126 mg/dL (7.0 mmol/L); blood pressure 
≥140/90 mmHg; current treatment with anti-
diabetes, anti-hypertension, anti-cholesterol, 
and anti-inflammatory medications; history of 
gastrointestinal resection and hormonal diseases; 
smoking; pregnancy and lactation. Those who 
were in weight loss program, using dietary fat 
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absorption inhibitor and anti-appetite drugs were 
also excluded. This study was approved by the 
Committee of Medical Research Ethics, Faculty 
of Medicine, University of Indonesia.
Study Design and Intervention 
This study was an 8-week open clinical trial. 
The subjects were assigned to receive a weight 
loss program consisting of the following goals: 
a 1,000 kcal reduction of total energy based on 
resting energy expenditure (REE) using WHO 
guideline and physical activity level of each 
subject.
Subjects attended 45-minute mild-to-moderate 
intensity exercise twice a week supervised 
by investigators at Balai Kota DKI Jaya and 
exercised for their remaining sessions once a 
week at home. Facility-based exercises included 
treadmill walking or stationary bicycling; while 
home exercise was a 45-minute brisk walking.
Study Measures and Data Collection
At the beginning, demographic information 
and a brief history of dietary and physical 
activity were recorded. There was 2-week wash 
out period prior to study. Subjects were seen at 
three scheduled visits (baseline or week 0, week 
4 and 8) during the study. Height was recorded 
using microtoise after removal of the subject’s 
shoes. Subjects also received diet consultation, 
menu, program journal, and exercise scheduled 
at Balai Kota sports center. Each subject was 
explained how to take note about dietary and 
exercise activity on journal. During each visit, 
the following assessments were performed: 
weight, waist circumference, fat mass, visceral 
fat rating, and triglyceride level.
Body weight, fat mass, and visceral mass 
rating were measured using 8 electrode method 
of Bio-Electrical Impedance Analysis (BIA) 
(MC-180 MA Tanita, Tokyo, Japan). Waist 
circumference was taken with subject in a 
standing position at level of the last rib and hip 
using measuring tape (Roche). Serum triglyceride 
was measured using spectrophotometry (Cobas 
c501, Roche).
Adherence to the intervention during the 
study was assessed via multiple approaches 
including phone call once a week, short message 
service (SMS) messaging twice a week, and one-
to-one session with the investigator once a week. 
Statistical Analysis 
A sample of 196 subjects were needed in 
order to provide 90% power (with p<0.05) and 
possible 10% drop out. Kolmogorov-Smirnov 
test was used to test data distribution. If p value 
>0.05, normality was established and presented 
as mean ± standard deviation, otherwise data 
were presented as median (minimum-maximum). 
Paired t-test was used to compare within group 
values of weight, waist circumference, fat mass, 
visceral mass rating, and triglyceride levels 
if data distribution was normal; otherwise the 
data was compared using Wilcoxon test. Values 
between WC and FEO groups were compared 
using independent t-test if the data was normally 
distributed; otherwise values were compared 
using Mann-Whitney test. Correlation between 
variables that were normally distributed was 
analyzed using Pearson test; otherwise Rank-
Spearman test was used. All analyses were 
carried out using statistical package for social 
sciences (SPSS) version 11.5 software and 
p<0.05 was considered statistically significant.
RESULTS
Of the initial 160 subjects who enrolled in 
the study, only 88 met the study criteria which 
consisted of 43 subjects in WC group and 45 in 
FEO group. Fifteen subjects withdrew prior to 
the study and one subject could not complete 
the program. Thus, the study was completed by 
72 subjects (n=34 subjects for the WC group 
and n=38 subjects for the FEO group). Because 
of limited sports equipment and staff, the study 
was held in three different period study: group 
I (n=25 subjects), group II (n=24 subjects), and 
group III (n=39 subjects). (Figure 1)
About 48.7% subjects in FEO group were 
men compared with WC group (23.5%) and the 
difference was statistically significant (p=0.026). 
All subjects in FEO group were significantly 
experienced obesity longer than WC group. All 
body composition variables between groups 
were not differ significantly except for fat mass 
(p=0.008). Visceral fat rating between both 
groups was not significantly different. However 
18 subjects in WC group (52.9%) and 27 subjects 
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in FEO group (69.2%) had visceral fat rating 
above normal (≥13). The difference between 
groups was not significant. (p=0.153).
Waist circumference and triglyceride level 
were two parameters used as metabolic syndrome 
markers in this study. Baseline triglyceride levels 
in FEO group were significantly higher than WC 
group (p=0.039).
Following 8-week weight loss program, 
changes of visceral fat rating are shown in Table 
2. There were no significant differences between 
groups.
Table 3 shows the changes of body weight 
and fat mass between groups during the study 
were not significantly different.
The decrease of waist circumference was 
smaller in WC group than FEO group. The 
highest changes during study were seen in both 
groups at the first four week. Triglyceride levels 
in WC group were elevated, while in FEO group 
triglyceride levels were reduced after 8-week 
program (4.12±54.11 vs 19.02±45.59 mg/dL); 
however, the difference was not significant 
(p=0.055).
Baseline triglyceride levels of five subjects 
in WC groups (14.7%) and 12 subjects (30.8%) 
in FEO group were above 150 mg/dL. At the end 
of the study, triglyceride levels of eight subjects 
in WC group (23.5%) and eight subjects in FEO 
group (21.1%) increased. The changes of waist 
Excluded:
- Withdrew (n=16)
- Hypertension (n=12)
- Diabetes Mellitus (n=3)
- Consuming hypoglycemic drugs (n=9)
88 subjects selected    : - WC group (n = 43)
Screening (n= 160)
Withdrew (n = 5) Withdrew (n = 5) Withdrew (n = 5)
Group I (n=25): Group II (n = 24): Group III  (n = 39):
Group  I (n =25): Group  II  (n = 24): Group III  (n = 39):
WASH OUT PERIODE : 2 Weeks
DIET AND EXERCISE PROGRAM (4 WEEKS)
DIET AND EXERCISE PROGRAM (4 WEEKS)
Group III (n = 34):
Group I (n = 20): Group  II (n = 19):
Group III  (n = 33):
WC (n = 18), FEO (n = 15)
(1 subject did not complete the study)
Group I (n = 20): Group  II (n = 19): Group III  (n = 33):
Data analyzed (n = 72)
Group  I (n = 20): Group  II (n = 19):
Consuming steroids (n=6)
Smokers (n=16)
Menopause (n=10)
-
-
-
FEO group (n = 45)-
WC (n=12), FEO (n=13) WC (n=10), FEO (n=14) WC (n=20), FEO (n=18)
WC (n=12), FEO (n=13) WC (n=10), FEO (n=14) WC (n=20), FEO (n=18)
WC (n=10), FEO (n=10) WC (n=6), FEO (n=13) WC (n=18), FEO (n=16)
WC (n=6), FEO (n=13)WC (n=10), FEO (n=10)
WC (n=10), FEO (n=10) WC (n=6), FEO (n=13) WC (n = 18), FEO (n = 15)
WC (n=34), FEO (n=38)
Figure 1. Flow diagram of the study
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circumference and triglyceride levels are shown 
in Table 4.
The correlation of all variables is shown in 
Table 5. Body weight, fat mass, and visceral fat 
rating in both groups were moderately correlated 
with waist circumference. Meanwhile, only the 
changes of body weight in WC group and fat 
mass in FEO group correlated with triglyceride 
levels with r=0.365, p=0.034 and r=0.351, 
p=0.031 respectively.
DISCUSSION
Baseline characteristics included age, family 
history of obesity, dietary intake, and physical 
activity of the subjects were comparable. There 
were more men in the FEO group and this might 
cause bias. Gender could interfere with body 
composition, this is shown by the difference 
of body composition between men and women 
at the same age.11 Oxidative stress is greater in 
men than women and it can affect body response 
to weight loss program. Smith et al.12 showed 
Table 1. Baseline characteristics of study population
Variables Weight cycling  (n = 34)
First encounter obesity  
(n = 39) p
Age (y) 38.00 (25.00-49.00) 40,00 (25.00-50.00) 0.859K
Gender
 - Male 8 (23.5%) 19 (48.7%) 
 - Female 26 (76.5%) 20 (51.3%) 0.026*C
Family history of obesity  
 - Yes 28 (81.3%) 30 (76.9%)
 - No 6 (17.6%) 9 (23.1%) 0.567C
Length of obesity (year)
 - Male 5.12 ± 2.69 11.68 ± 4.61 <0.001T*
 - Female 6.58 ± 2.33 12.25 ± 6.73 0.002T*
Food intake
Energy (kcal) 2343.76 ± 609.56 2568.19 ± 821.55 0.186T
 - Carbohydrate (g) 244.57 ± 89.13 266.05 (107.00-570.00) 0.089M
 - Protein (g) 90.27 (61.00-178.55) 104.84 ± 35.12 0.274M
 - Fat (g) 109.41 ± 38.64 114.16 ± 45.48 0.632T
Dietary composition in percentage
 - Carbohydrate (%) 43.00 ± 7.00 44.00 ± 8.00 0.738T
 - Protein (%) 16.00 ± 3.00 16.00 ± 3.00 0.965T
 - Fat (%) 40.00 ± 7.00 39.00 ± 8.00 0.819T
Physical activity (n)
 - Mild 10 (29.4%) 14(35.9%)
 - Moderate 22 (64.7%) 21 (53.8%)
 - High 2 (5.9%) 4 (10.3%) 0.601*C
Body composition
 - Body weight (kg) 82.99 ± 9,78 82.25 ± 9,65 0.745T
 - Height (m) 1.57 (1.46-1.76) 1.59 (1.44-1.78) 0.634M
 - Body mass index (kg/m2) 31.85 (30.00-35.30) 31.20 (30.00-35.00) 0.306M
 - Fat mass (kg) 35.51 ± 6.51 31.19 ± 6.93 0.008T*
 - Visceral fat rating 13.00 (9.00-19.00) 14,00 (8,00-19,00) 0.218M
Metabolic syndrome markers
 - Waist circumference (cm) 101.16 ± 6.74 103.09 ± 6.76 0.226T
 - Triglyceride (mg/dL) 96.00 (43.00-305.00) 133.00 (50.00-342.00) 0.039M*
Cchi-square, T independent t test, M Mann Whitney, *significant (p < 0.05)
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that the response of muscle protein synthesis 
after endurance exercise was different between 
men and women. An animal study by Valle et 
al.13 showed the energy balance response to the 
caloric restriction and muscle protein synthesis 
response to exercise differ according to gender. 
Macronutrient proportions in both group showed 
high proportion of fat which may contribute to 
the pathogenesis of obesity. Fatty acids trigger 
peroxisome proliferator-activated receptors delta 
(PPAR d) and gamma (PPAR γ) receptor, which 
may induce adipogenesis and fat deposition in 
adipose tissue.14
Subjects in WC group had higher fat mass and 
the result was similar with other references that 
suggested WC was correlated with adipogenesis 
and hyperplasia of adipose by alteration of fat 
metabolism.15 One of the possibilities that WC 
may promote fat deposition in adipose tissue 
is that WC induces the fluctuation of lipogenic 
enzyme, cholesterol, triglyceride, glucose, 
insulin and glucagon levels by the alterations 
Table 2. Changes of visceral fat rating during the program
Visceral 
fat rating
Weight 
cycling  
(n = 34)
First Encounter 
Obesity  
(n = 38)
p
W0 13.00  
(9.00-19.00)
14.00  
(8.00-19.00) 0.169
M
W4 12,03 ± 2,43 12.42 ± 2.81 0.528T
W8 11.00  
(7.00-18.00)
12.50  
(7.00-17.00) 0.208
M
 - Δ W4-W0 -1.00  
(-3.00–1.00)
-1.00  
(-4.00–0.00) 0.269
M
 - Δ W8-W4 -1.00  
(-2.00–1.00)
0.00  
(-2.00–2.00) 0.571
M
 - Δ W8-W0 -1.50  
(-4.00–1.00)
-2.00  
(-4.00–0.00) 0.560
M
T independent t test, M Mann Whitney, *significant (p <0.05), 
W0: baseline, W4: week 4, W8: week 8, Δ: changes
Table 3. Changes of body weight and fat mass during 
the study
Variables
Weight 
cycling  
(n = 34)
First Encounter 
Obesity  
(n = 38)
p
BW (kg)
M0 82.99 ± 9.78 82.47 ± 9.68 0.817T
M4 79.41 ± 9.36 78.21 ± 8.97 0.579T
M8 78.08 ± 9.69 76.75 ± 8.73 0.546T
 - Δ M4-M0 -3.58 ± 2.18 -4.25 ± 2.11 0.189T
 - Δ M8-M4 -1.34 ± 1.55 -1.46 ± 1.74 0.764T
 - Δ M8-M0 -4.92 ± 3.20 -5.71 ± 3.10 0.292T
Fat mass (kg)
M0 35.51 ± 6,51 31.19 ± 7.02 0.008T*
M4 32.69 ± 6.19 28.37 ± 6.76 0.006T*
M8 31.71 ± 6.36 27.31 ± 6.41 0.005T*
 - Δ M4-M0 -2.82 ± 2.02 -2.81 ± 1.74 0.986T
 - Δ M8-M4 -0.98 ± 1.39 -1.07 ± 1.54 0.797T
 - Δ M8-M0 -3.80 ± 2.84 -3.88 ± 2.33 0.895T
T independent t test, * significant (p <0.05), BW: body 
weight, W0: baseline, W4: week 4, W8: week 8, Δ: changes
Table 4. Changes of metabolic syndrome markers during the study
Variables Weight cycling (n=34) First encounter obesity (n=38) p
Waist circumference (cm)
W0 101.16 ± 6.75 103.27 ± 6.76 0.190T
W4 97.61 ± 7.48 99.17 ± 6.39 0.350T
W8 95.34 ± 7.07 96.31 ± 6.25 0.543T
 - Δ W4-W0 -3.55 ± 3.42 -4.10 ± 2.87 0.459T
 - Δ W8-W4 -1.50 (-8.00–1.80) -2.25 (-7.50–3.00) 0.158M
 - Δ W8-W0 -5.82 ± 4.38 -6.97 ± 3.59 0.233T
Triglyceride (mg/dL)
W0 96.00 (43.00–305.00) 134.50 (50.00–342.00) 0.030M*
W4 88.00 (47.00–311.00) 96.50 (45.00–377.00) 0.524M
W8 99.00 (44.00–428.00) 103.00 (54.00–310.00) 0.502M
 - Δ W4-W0 -0.50 (-118.00–95.00) -23,00 (-119.00–199.00) 0.024M*
 - Δ W8-W4 4.50 (-88.00–200.00) 5.50 (-111.00–84.00) 0.982M
 - Δ W8-W0 4.12 ± 54.11 -19.02 ± 45.59 0.055T
T independent t test, M Mann Whitney,  *significant (p <0.05), W0: baseline, W4: week 4, W8:  week 8, Δ: changes
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of metabolism and genetic expression. Another 
possibility is that fat deposition correlates with 
leptin level and lipogenic enzyme stimulation in 
white adipose matter. Caloric restriction followed 
by exaggerate feeding could promote an increase 
in adipose tissue which respond to changes 
of energy supply by the release of leptin and 
adiponectin. The increase of lipogenic activity 
and leptin level could contribute to weight gain 
in WC.16
Following weight loss program consisting 
of energy-reduction diet and exercise, there 
were loss of body weight loss and fat mass in 
both groups. There were various studies that 
demonstrated the loss of body weight and fat 
mass after diet and/or exercise intervention. 
Kempen et al.17 demonstrated that addition of 
exercise to 4-week energy-restricted diet in 
obese women has advantages to the changes in 
body composition including body weight and 
fat mass. Study by Geliebter et al.18 showed that 
in diet plus aerobic training group, mean body 
weight and fat mass reduced 9.2 ± 4.5% and 7.2 
± 3.0% respectively although the difference did 
not differ significantly compared with diet plus 
strength training and diet alone groups.
The present study showed at the first four 
weeks, the loss of fat mass was higher than 
second four weeks study in both groups. At the 
end of study, the loss of fat mass in WC group 
was lower than FEO group and the difference 
was not significant. This result demonstrated the 
response of subjects in FEO group to the program 
was better than WC group. Similarly, Yoo et al.19 
demonstrated that a decrease in body weight and 
fat mass was greater in non-WC group compared 
with WC group after 12 weeks of the weight 
control program; however, the difference was not 
significant. It is conceivable that diet and exercise 
have fewer advantages in weight cyclers. It is 
suggested that weight cyclers have a lower basal 
metabolic rate which makes it difficult to control 
long term stable body weight. Therefore, weight 
cyclers tend to experience weight regain.
Visceral fat rating may reflect the amount 
of abdominal visceral fat. This study showed 
mean visceral fat rating in both groups did not 
differ significantly. However, most of subjects 
in FEO group (69.2%) and WC group (52.9%) 
had visceral fat rating above normal (>13). It 
is suggested that there were more men in FEO 
group which abdominal fat in men is larger than 
women.20
There are many criteria proposed to describe 
metabolic syndrome, but Despre et al.21 proposed 
hypertriglyceridemic waist (hypertriglyceridemia 
and high waist circumference) as a simple 
criteria for early screening to identify metabolic 
syndrome. Baseline waist circumference of 
all subjects was larger than normal values. Fat 
accumulation in obesity, especially visceral 
fat, has been known correlated with metabolic 
syndrome.22 A study of Lemieux et al.23 showed a 
positive association between waist circumference 
and apolipoprotein B level, it is suggested due 
to accumulation of visceral adipose tissue. The 
study also showed in men, fasting insulin levels 
increased consistently with waist circumference.
Baseline triglyceride levels in FEO group 
were higher than WC group. It might correlate 
with waist circumference which was higher 
in FEO group. Waist circumference is well 
recognized to predispose intraperitoneal fat and 
abdominal or intraperitoneal fat is predisposing 
factor for hypertriglyceridemia. The mechanism 
for this relationship is that intraperitoneal fat 
releases fatty acids directly into the splanchnic 
circulation. These fatty acids may add a lipid load 
Table 5. Correlation the changes of body weight, body 
composition (fat mass and visceral fat rating) and metabolic 
syndrome markers in WC and FEO groups
Variables
Metabolic syndrome markers
∆ waist 
circumference
∆ triglyceride 
levels
r p r p
WC group
 - ∆ BW 0.404 <0,001P* 0.365 0,034P*
 - ∆ FM 0.445 0.008P* 0.314 0.071P
 - ∆ visceral fat 
rating 0.321 <0,001
P* 0.225 0.201P
FEO group
 - ∆ BW 0.546 <0.001P* 0.235 0.155S
 - ∆ FM 0.555 <0.001P* 0.351 0.031S*
 - ∆ visceral fat 
rating 0.603 <0.001
P* 0.281 0.088S
P Pearson test, S Rank-Spearman test,* significant 
(p<0.05), BW: body weight, FM: fat mass, r: coefficient 
of correlation
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on the liver thus this extra load should translate 
into higher triglyceride levels.24
  Sex difference may also influence triglyceride 
levels via the action of estrogen hormone. 
Estrogen has role in suppress lipoprotein lipase 
enzyme activity in plasma and adipose tissue. 
Estrogen also has an inhibitory effect on fat 
deposition, especially visceral fat via unclear 
mechanism.25 In this study, there were more 
women in WC group which might correlated with 
lower triglyceride levels in WC group.
No subjects has normal waist circumference 
until the end of study. However, there was a 
higher decrease in waist circumference in FEO 
group than WC group which it was significantly 
different. A decrease in waist circumference might 
have correlation with weight loss. Analysis in this 
study showed moderate correlation between 
body weight and waist circumference in both 
groups. The correlation of body weight changes 
with waist circumference after 1-year follow up 
was also shown in study by Miyatake et al.26 A 
decrease in body weight of 3 kg corresponded 
to a decrease in waist circumference of 3.45 cm 
in men and 2.83 cm in women. Other study by 
Egger et al.27 showed 0.75 kg weight loss equals 
as 1 cm reduction of waist circumference.
Weight loss program in this study did not 
contribute significant effect in triglyceride 
levels. However, FEO group had better response 
to the program which the triglyceride levels 
significantly decreased after 4-week program 
although no significant difference at the end 
of study between groups. An animal study of 
Barbosa-da-Silva et al.28 demonstrated WC 
caused dysregulated lipid metabolism which 
mild reduction of fat mass is not able to recover 
the high levels of adipokines in serum and 
adipose tissue.
Weight cycling theoretically may influence 
blood lipid but in this study, baseline triglyceride 
levels in FEO group was higher than WC group. 
It was suggested that subjects in FEO group 
experienced obesity longer than subjects in 
WC group. The changes of body composition 
following the program may promote better 
response in FEO groups, which triglyceride 
levels decreased, although the decrease was not 
significant compared with WC group. It was 
also shown that the changes of body weight 
and composition in this study only had weak 
correlation with triglyceride levels in both 
groups. Grundy SM et al.24 demonstrated that 
intra peritoneal fat correlated with triglyceride 
levels. Meanwhile, Ribeiro-Filho et al.29 shown 
there was a weak correlation between triglyceride 
levels and waist circumference.
Both markers of metabolic syndrome 
are well recognized to have correlation with 
visceral fat. In this study, there was a decrease 
in visceral fat rating in both groups. At baseline, 
18 subjects (52.9%) in WC group had visceral 
fat rating above normal value and it decreased 
to only 13 subjects (38.4%) at  week 4; and 11 
subjects (32.4%) at the end of study. Meanwhile 
in FEO group, at baseline 27 subjects (69,2%) 
had visceral fat rating above and it decreased into 
20 subjects (52.6%) at week 4; and 19 subjects 
(50%) at the end of study. It may suggest the 
decrease may related with a decrease in waist 
circumference. Statistical analysis showed that 
visceral fat rating was moderately correlated with 
waist circumference in FEO group (r=0.603, 
p<0.001), while the correlation in WC group 
was weaker (r=0.321, p<0.001). There were 
various results regarding the correlation between 
visceral fat and waist circumference. Prado et 
al.30 showed a moderate correlation between 
waist circumference and visceral fat measured 
by ultrasound examination (r=0.615, p<0.001). 
In that study, visceral fat thickness also showed 
the best correlation with metabolic syndrome 
components. Similar result was also shown in 
study by Ribeiro-Filho et al.29 waist circumference 
was moderate and strong correlated with visceral 
fat measured by computed tomography (CT) and 
ultrasound respectively. A marked correlation 
between visceral fat and triglyceride levels could 
not be established in the present study.
The current study was the first clinical trial 
in Indonesia to assess the effect of a weight loss 
program in WC on changes of body composition 
and parameters of metabolic syndrome, while the 
control group was those who never experienced 
weight cycling (or FEO). There were several 
limitations including no randomization and 
blinding but the same intervention was applied 
to two groups with different characteristics. Also, 
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the original sample size could not be achieved 
due to limited time of the study.
CONCLUSION
The weight loss program may contribute 
to changes in body composition and markers 
of metabolic syndrome in obese subjects. The 
response appears to be worse in weight cyclers 
comparing with FEO. Further studies are 
required to confirm these findings and the exact 
mechanisms responsible for these results.
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